APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Aprepitant

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Aprepitant Market Analysis and Forecast 2026-2032

Report ID 173967030222 December 2025191 pages

Choose your research edition.

Industry ResearchAprepitant Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Aprepitant Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Aprepitant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aprepitant Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Aprepitant Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Aprepitant market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Aprepitant is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Aprepitant is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Aprepitant is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Aprepitant is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Aprepitant include Shanghai Yingrui Biomedical Technology Co., Ltd., Sandoz, Merck & Co., Vea Impex (I) Pvt. Ltd., Heron Therapeutics, Glenmark Pharmaceuticals, Aetos Pharma, Actiza Pharmaceutical and Aark Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Aprepitant, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Aprepitant, also provides the sales of main regions and countries. Of the upcoming market potential for Aprepitant, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Aprepitant sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Aprepitant market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Aprepitant sales, projected growth trends, production technology, application and end-user industry.

Aprepitant Segment by Company

Shanghai Yingrui Biomedical Technology Co., Ltd.

Sandoz

Merck & Co.

Vea Impex (I) Pvt. Ltd.

Heron Therapeutics

Glenmark Pharmaceuticals

Aetos Pharma

Actiza Pharmaceutical

Aark Pharmaceuticals

Aprepitant Segment by Type

Injection

Oral

Aprepitant Segment by Application

Hospital

Drug store

Aprepitant Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aprepitant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aprepitant and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aprepitant.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Aprepitant in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Aprepitant manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Aprepitant sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Aprepitant Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injection Major Manufacturers Table 3. Oral Major Manufacturers Table 4. Global Aprepitant Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Drug store Major Manufacturers Table 7. Aprepitant Industry Trends Table 8. Aprepitant Industry Drivers Table 9. Aprepitant Industry Opportunities and Challenges Table 10. Aprepitant Industry Restraints Table 11. Global Aprepitant Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Aprepitant Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Aprepitant Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Aprepitant Revenue Market Share by Region (2021-2026) Table 15. Global Aprepitant Revenue Market Share by Region (2027-2032) Table 16. Global Aprepitant Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Aprepitant Sales by Region (2021-2026) & (k units) Table 18. Global Aprepitant Sales by Region (2027-2032) & (k units) Table 19. Global Aprepitant Sales Market Share by Region (2021-2026) Table 20. Global Aprepitant Sales Market Share by Region (2027-2032) Table 21. Global Aprepitant Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Aprepitant Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Aprepitant Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Aprepitant Sales Market Share by Manufacturers (2021-2026) Table 25. Global Aprepitant Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Aprepitant Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Aprepitant Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Aprepitant Manufacturers, Product Type & Application Table 29. Global Aprepitant Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Aprepitant by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Aprepitant Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Aprepitant Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Aprepitant Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Aprepitant Revenue Market Share by Type (2021-2026) Table 36. Global Aprepitant Revenue Market Share by Type (2027-2032) Table 37. Global Aprepitant Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Aprepitant Sales by Type (2021-2026) & (k units) Table 39. Global Aprepitant Sales by Type (2027-2032) & (k units) Table 40. Global Aprepitant Sales Market Share by Type (2021-2026) Table 41. Global Aprepitant Sales Market Share by Type (2027-2032) Table 42. Global Aprepitant Price by Type (2021-2026) & (US$/unit) Table 43. Global Aprepitant Price by Type (2027-2032) & (US$/unit) Table 44. Global Aprepitant Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Aprepitant Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Aprepitant Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Aprepitant Revenue Market Share by Application (2021-2026) Table 48. Global Aprepitant Revenue Market Share by Application (2027-2032) Table 49. Global Aprepitant Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Aprepitant Sales by Application (2021-2026) & (k units) Table 51. Global Aprepitant Sales by Application (2027-2032) & (k units) Table 52. Global Aprepitant Sales Market Share by Application (2021-2026) Table 53. Global Aprepitant Sales Market Share by Application (2027-2032) Table 54. Global Aprepitant Price by Application (2021-2026) & (US$/unit) Table 55. Global Aprepitant Price by Application (2027-2032) & (US$/unit) Table 56. Shanghai Yingrui Biomedical Technology Co., Ltd. Company Information Table 57. Shanghai Yingrui Biomedical Technology Co., Ltd. Business Overview Table 58. Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Product Portfolio Table 60. Shanghai Yingrui Biomedical Technology Co., Ltd. Recent Development Table 61. Sandoz Company Information Table 62. Sandoz Business Overview Table 63. Sandoz Aprepitant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Sandoz Aprepitant Product Portfolio Table 65. Sandoz Recent Development Table 66. Merck & Co. Company Information Table 67. Merck & Co. Business Overview Table 68. Merck & Co. Aprepitant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Merck & Co. Aprepitant Product Portfolio Table 70. Merck & Co. Recent Development Table 71. Vea Impex (I) Pvt. Ltd. Company Information Table 72. Vea Impex (I) Pvt. Ltd. Business Overview Table 73. Vea Impex (I) Pvt. Ltd. Aprepitant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Vea Impex (I) Pvt. Ltd. Aprepitant Product Portfolio Table 75. Vea Impex (I) Pvt. Ltd. Recent Development Table 76. Heron Therapeutics Company Information Table 77. Heron Therapeutics Business Overview Table 78. Heron Therapeutics Aprepitant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Heron Therapeutics Aprepitant Product Portfolio Table 80. Heron Therapeutics Recent Development Table 81. Glenmark Pharmaceuticals Company Information Table 82. Glenmark Pharmaceuticals Business Overview Table 83. Glenmark Pharmaceuticals Aprepitant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Glenmark Pharmaceuticals Aprepitant Product Portfolio Table 85. Glenmark Pharmaceuticals Recent Development Table 86. Aetos Pharma Company Information Table 87. Aetos Pharma Business Overview Table 88. Aetos Pharma Aprepitant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Aetos Pharma Aprepitant Product Portfolio Table 90. Aetos Pharma Recent Development Table 91. Actiza Pharmaceutical Company Information Table 92. Actiza Pharmaceutical Business Overview Table 93. Actiza Pharmaceutical Aprepitant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Actiza Pharmaceutical Aprepitant Product Portfolio Table 95. Actiza Pharmaceutical Recent Development Table 96. Aark Pharmaceuticals Company Information Table 97. Aark Pharmaceuticals Business Overview Table 98. Aark Pharmaceuticals Aprepitant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Aark Pharmaceuticals Aprepitant Product Portfolio Table 100. Aark Pharmaceuticals Recent Development Table 101. North America Aprepitant Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Aprepitant Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Aprepitant Sales by Type (2021-2026) & (k units) Table 104. North America Aprepitant Sales by Type (2027-2032) & (k units) Table 105. North America Aprepitant Sales Price by Type (2021-2026) & (US$/unit) Table 106. North America Aprepitant Sales Price by Type (2027-2032) & (US$/unit) Table 107. North America Aprepitant Revenue by Application (2021-2026) & (US$ Million) Table 108. North America Aprepitant Revenue by Application (2027-2032) & (US$ Million) Table 109. North America Aprepitant Sales by Application (2021-2026) & (k units) Table 110. North America Aprepitant Sales by Application (2027-2032) & (k units) Table 111. North America Aprepitant Sales Price by Application (2021-2026) & (US$/unit) Table 112. North America Aprepitant Sales Price by Application (2027-2032) & (US$/unit) Table 113. North America Aprepitant Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Aprepitant Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 115. North America Aprepitant Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 116. North America Aprepitant Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 117. North America Aprepitant Sales by Country (2021-2026) & (k units) Table 118. North America Aprepitant Sales by Country (2027-2032) & (k units) Table 119. North America Aprepitant Sales Price by Country (2021-2026) & (US$/unit) Table 120. North America Aprepitant Sales Price by Country (2027-2032) & (US$/unit) Table 121. United States Aprepitant Revenue (2021-2032) & (US$ Million) Table 122. Canada Aprepitant Revenue (2021-2032) & (US$ Million) Table 123. Mexico Aprepitant Revenue (2021-2032) & (US$ Million) Table 124. Europe Aprepitant Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Aprepitant Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Aprepitant Sales by Type (2021-2026) & (k units) Table 127. Europe Aprepitant Sales by Type (2027-2032) & (k units) Table 128. Europe Aprepitant Sales Price by Type (2021-2026) & (US$/unit) Table 129. Europe Aprepitant Sales Price by Type (2027-2032) & (US$/unit) Table 130. Europe Aprepitant Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe Aprepitant Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe Aprepitant Sales by Application (2021-2026) & (k units) Table 133. Europe Aprepitant Sales by Application (2027-2032) & (k units) Table 134. Europe Aprepitant Sales Price by Application (2021-2026) & (US$/unit) Table 135. Europe Aprepitant Sales Price by Application (2027-2032) & (US$/unit) Table 136. Europe Aprepitant Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Aprepitant Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. Europe Aprepitant Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. Europe Aprepitant Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 140. Europe Aprepitant Sales by Country (2021-2026) & (k units) Table 141. Europe Aprepitant Sales by Country (2027-2032) & (k units) Table 142. Europe Aprepitant Sales Price by Country (2021-2026) & (US$/unit) Table 143. Europe Aprepitant Sales Price by Country (2027-2032) & (US$/unit) Table 144. Germany Aprepitant Revenue (2021-2032) & (US$ Million) Table 145. France Aprepitant Revenue (2021-2032) & (US$ Million) Table 146. U.K. Aprepitant Revenue (2021-2032) & (US$ Million) Table 147. Italy Aprepitant Revenue (2021-2032) & (US$ Million) Table 148. Russia Aprepitant Revenue (2021-2032) & (US$ Million) Table 149. Spain Aprepitant Revenue (2021-2032) & (US$ Million) Table 150. Netherlands Aprepitant Revenue (2021-2032) & (US$ Million) Table 151. Switzerland Aprepitant Revenue (2021-2032) & (US$ Million) Table 152. Sweden Aprepitant Revenue (2021-2032) & (US$ Million) Table 153. Poland Aprepitant Revenue (2021-2032) & (US$ Million) Table 154. China Aprepitant Revenue by Type (2021-2026) & (US$ Million) Table 155. China Aprepitant Revenue by Type (2027-2032) & (US$ Million) Table 156. China Aprepitant Sales by Type (2021-2026) & (k units) Table 157. China Aprepitant Sales by Type (2027-2032) & (k units) Table 158. China Aprepitant Sales Price by Type (2021-2026) & (US$/unit) Table 159. China Aprepitant Sales Price by Type (2027-2032) & (US$/unit) Table 160. China Aprepitant Revenue by Application (2021-2026) & (US$ Million) Table 161. China Aprepitant Revenue by Application (2027-2032) & (US$ Million) Table 162. China Aprepitant Sales by Application (2021-2026) & (k units) Table 163. China Aprepitant Sales by Application (2027-2032) & (k units) Table 164. China Aprepitant Sales Price by Application (2021-2026) & (US$/unit) Table 165. China Aprepitant Sales Price by Application (2027-2032) & (US$/unit) Table 166. Asia Aprepitant Revenue by Type (2021-2026) & (US$ Million) Table 167. Asia Aprepitant Revenue by Type (2027-2032) & (US$ Million) Table 168. Asia Aprepitant Sales by Type (2021-2026) & (k units) Table 169. Asia Aprepitant Sales by Type (2027-2032) & (k units) Table 170. Asia Aprepitant Sales Price by Type (2021-2026) & (US$/unit) Table 171. Asia Aprepitant Sales Price by Type (2027-2032) & (US$/unit) Table 172. Asia Aprepitant Revenue by Application (2021-2026) & (US$ Million) Table 173. Asia Aprepitant Revenue by Application (2027-2032) & (US$ Million) Table 174. Asia Aprepitant Sales by Application (2021-2026) & (k units) Table 175. Asia Aprepitant Sales by Application (2027-2032) & (k units) Table 176. Asia Aprepitant Sales Price by Application (2021-2026) & (US$/unit) Table 177. Asia Aprepitant Sales Price by Application (2027-2032) & (US$/unit) Table 178. Asia Aprepitant Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Asia Aprepitant Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. Asia Aprepitant Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. Asia Aprepitant Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 182. Asia Aprepitant Sales by Country (2021-2026) & (k units) Table 183. Asia Aprepitant Sales by Country (2027-2032) & (k units) Table 184. Asia Aprepitant Sales Price by Country (2021-2026) & (US$/unit) Table 185. Asia Aprepitant Sales Price by Country (2027-2032) & (US$/unit) Table 186. Japan Aprepitant Revenue (2021-2032) & (US$ Million) Table 187. South Korea Aprepitant Revenue (2021-2032) & (US$ Million) Table 188. India Aprepitant Revenue (2021-2032) & (US$ Million) Table 189. Australia Aprepitant Revenue (2021-2032) & (US$ Million) Table 190. Taiwan Aprepitant Revenue (2021-2032) & (US$ Million) Table 191. Southeast Asia Aprepitant Revenue (2021-2032) & (US$ Million) Table 192. SAMEA Aprepitant Revenue by Type (2021-2026) & (US$ Million) Table 193. SAMEA Aprepitant Revenue by Type (2027-2032) & (US$ Million) Table 194. SAMEA Aprepitant Sales by Type (2021-2026) & (k units) Table 195. SAMEA Aprepitant Sales by Type (2027-2032) & (k units) Table 196. SAMEA Aprepitant Sales Price by Type (2021-2026) & (US$/unit) Table 197. SAMEA Aprepitant Sales Price by Type (2027-2032) & (US$/unit) Table 198. SAMEA Aprepitant Revenue by Application (2021-2026) & (US$ Million) Table 199. SAMEA Aprepitant Revenue by Application (2027-2032) & (US$ Million) Table 200. SAMEA Aprepitant Sales by Application (2021-2026) & (k units) Table 201. SAMEA Aprepitant Sales by Application (2027-2032) & (k units) Table 202. SAMEA Aprepitant Sales Price by Application (2021-2026) & (US$/unit) Table 203. SAMEA Aprepitant Sales Price by Application (2027-2032) & (US$/unit) Table 204. SAMEA Aprepitant Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. SAMEA Aprepitant Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. SAMEA Aprepitant Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. SAMEA Aprepitant Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 208. SAMEA Aprepitant Sales by Country (2021-2026) & (k units) Table 209. SAMEA Aprepitant Sales by Country (2027-2032) & (k units) Table 210. SAMEA Aprepitant Sales Price by Country (2021-2026) & (US$/unit) Table 211. SAMEA Aprepitant Sales Price by Country (2027-2032) & (US$/unit) Table 212. Brazil Aprepitant Revenue (2021-2032) & (US$ Million) Table 213. Argentina Aprepitant Revenue (2021-2032) & (US$ Million) Table 214. Chile Aprepitant Revenue (2021-2032) & (US$ Million) Table 215. Colombia Aprepitant Revenue (2021-2032) & (US$ Million) Table 216. Peru Aprepitant Revenue (2021-2032) & (US$ Million) Table 217. Saudi Arabia Aprepitant Revenue (2021-2032) & (US$ Million) Table 218. Israel Aprepitant Revenue (2021-2032) & (US$ Million) Table 219. UAE Aprepitant Revenue (2021-2032) & (US$ Million) Table 220. Turkey Aprepitant Revenue (2021-2032) & (US$ Million) Table 221. Iran Aprepitant Revenue (2021-2032) & (US$ Million) Table 222. Egypt Aprepitant Revenue (2021-2032) & (US$ Million) Table 223. Key Raw Materials Table 224. Raw Materials Key Suppliers Table 225. Aprepitant Distributors List Table 226. Aprepitant Customers List Table 227. Research Programs/Design for This Report Table 228. Authors List of This Report Table 229. Secondary Sources Table 230. Primary Sources List of Figures Figure 1. Aprepitant Image Figure 2. Global Aprepitant Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Aprepitant Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injection Image Figure 5. Oral Image Figure 6. Global Aprepitant Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Aprepitant Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Drug store Image Figure 10. Global Aprepitant Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Aprepitant Revenue (2021-2032) & (US$ Million) Figure 12. Global Aprepitant Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Aprepitant Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Aprepitant Revenue Market Share by Region (2021-2032) Figure 15. Global Aprepitant Sales (2021-2032) & (k units) Figure 16. Global Aprepitant Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Aprepitant Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Aprepitant Sales YoY (2021-2032) & (k units) Figure 19. Europe Aprepitant Sales YoY (2021-2032) & (k units) Figure 20. China Aprepitant Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Aprepitant Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Aprepitant Sales YoY (2021-2032) & (k units) Figure 23. Global Aprepitant Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Aprepitant Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Aprepitant Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Aprepitant Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Aprepitant Revenue Market Share by Type (2021-2032) Figure 29. Global Aprepitant Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Aprepitant Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Aprepitant Sales Market Share by Type (2021-2032) Figure 32. Global Aprepitant Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Aprepitant Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Aprepitant Revenue Market Share by Application (2021-2032) Figure 35. Global Aprepitant Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Aprepitant Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Aprepitant Sales Market Share by Application (2021-2032) Figure 38. North America Aprepitant Revenue Share by Type (2021-2032) Figure 39. North America Aprepitant Sales Share by Type (2021-2032) Figure 40. North America Aprepitant Revenue Share by Application (2021-2032) Figure 41. North America Aprepitant Sales Share by Application (2021-2032) Figure 42. North America Aprepitant Revenue Share by Country (2021-2032) Figure 43. North America Aprepitant Sales Share by Country (2021-2032) Figure 44. Europe Aprepitant Revenue Share by Type (2021-2032) Figure 45. Europe Aprepitant Sales Share by Type (2021-2032) Figure 46. Europe Aprepitant Revenue Share by Application (2021-2032) Figure 47. Europe Aprepitant Sales Share by Application (2021-2032) Figure 48. Europe Aprepitant Revenue Share by Country (2021-2032) Figure 49. Europe Aprepitant Sales Share by Country (2021-2032) Figure 50. China Aprepitant Revenue Share by Type (2021-2032) Figure 51. China Aprepitant Sales Share by Type (2021-2032) Figure 52. China Aprepitant Revenue Share by Application (2021-2032) Figure 53. China Aprepitant Sales Share by Application (2021-2032) Figure 54. Asia Aprepitant Revenue Share by Type (2021-2032) Figure 55. Asia Aprepitant Sales Share by Type (2021-2032) Figure 56. Asia Aprepitant Revenue Share by Application (2021-2032) Figure 57. Asia Aprepitant Sales Share by Application (2021-2032) Figure 58. Asia Aprepitant Revenue Share by Country (2021-2032) Figure 59. Asia Aprepitant Sales Share by Country (2021-2032) Figure 60. SAMEA Aprepitant Revenue Share by Type (2021-2032) Figure 61. SAMEA Aprepitant Sales Share by Type (2021-2032) Figure 62. SAMEA Aprepitant Revenue Share by Application (2021-2032) Figure 63. SAMEA Aprepitant Sales Share by Application (2021-2032) Figure 64. SAMEA Aprepitant Revenue Share by Country (2021-2032) Figure 65. SAMEA Aprepitant Sales Share by Country (2021-2032) Figure 66. Aprepitant Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Aprepitant Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Oral
Applications
  • Hospital
  • Drug store
Companies covered
  • Shanghai Yingrui Biomedical Technology Co., Ltd.
  • Sandoz
  • Merck & Co.
  • Vea Impex (I) Pvt. Ltd.
  • Heron Therapeutics
  • Glenmark Pharmaceuticals
  • Aetos Pharma
  • Actiza Pharmaceutical
  • Aark Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Aprepitant Market by Type
  3. 1.2.1 Global Aprepitant Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injection
  5. 1.2.3 Oral
  6. 1.3 Aprepitant Market by Application
  7. 1.3.1 Global Aprepitant Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Drug store
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Aprepitant Market Dynamics
  1. 2.1 Aprepitant Industry Trends
  2. 2.2 Aprepitant Industry Drivers
  3. 2.3 Aprepitant Industry Opportunities and Challenges
  4. 2.4 Aprepitant Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Aprepitant Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Aprepitant Revenue by Region
  3. 3.2.1 Global Aprepitant Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Aprepitant Revenue by Region (2021-2026)
  5. 3.2.3 Global Aprepitant Revenue by Region (2027-2032)
  6. 3.2.4 Global Aprepitant Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Aprepitant Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Aprepitant Sales by Region
  9. 3.4.1 Global Aprepitant Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Aprepitant Sales by Region (2021-2026)
  11. 3.4.3 Global Aprepitant Sales by Region (2027-2032)
  12. 3.4.4 Global Aprepitant Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Aprepitant Revenue by Manufacturers
  2. 4.1.1 Global Aprepitant Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Aprepitant Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Aprepitant Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Aprepitant Sales by Manufacturers
  6. 4.2.1 Global Aprepitant Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Aprepitant Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Aprepitant Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Aprepitant Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Aprepitant Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Aprepitant Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Aprepitant Manufacturers, Product Type & Application
  13. 4.7 Global Aprepitant Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Aprepitant Market CR5 and HHI
  16. 4.8.2 2025 Aprepitant Tier 1, Tier 2, and Tier 3
5 Aprepitant Market by Type
  1. 5.1 Global Aprepitant Revenue by Type
  2. 5.1.1 Global Aprepitant Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Aprepitant Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Aprepitant Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Aprepitant Sales by Type
  6. 5.2.1 Global Aprepitant Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Aprepitant Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Aprepitant Sales Market Share by Type (2021-2032)
  9. 5.3 Global Aprepitant Price by Type
6 Aprepitant Market by Application
  1. 6.1 Global Aprepitant Revenue by Application
  2. 6.1.1 Global Aprepitant Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Aprepitant Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Aprepitant Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Aprepitant Sales by Application
  6. 6.2.1 Global Aprepitant Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Aprepitant Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Aprepitant Sales Market Share by Application (2021-2032)
  9. 6.3 Global Aprepitant Price by Application
7 Company Profiles
  1. 7.1 Shanghai Yingrui Biomedical Technology Co., Ltd.
  2. 7.1.1 Shanghai Yingrui Biomedical Technology Co., Ltd. Company Information
  3. 7.1.2 Shanghai Yingrui Biomedical Technology Co., Ltd. Business Overview
  4. 7.1.3 Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Product Portfolio
  6. 7.1.5 Shanghai Yingrui Biomedical Technology Co., Ltd. Recent Developments
  7. 7.2 Sandoz
  8. 7.2.1 Sandoz Company Information
  9. 7.2.2 Sandoz Business Overview
  10. 7.2.3 Sandoz Aprepitant Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sandoz Aprepitant Product Portfolio
  12. 7.2.5 Sandoz Recent Developments
  13. 7.3 Merck & Co.
  14. 7.3.1 Merck & Co. Company Information
  15. 7.3.2 Merck & Co. Business Overview
  16. 7.3.3 Merck & Co. Aprepitant Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck & Co. Aprepitant Product Portfolio
  18. 7.3.5 Merck & Co. Recent Developments
  19. 7.4 Vea Impex (I) Pvt. Ltd.
  20. 7.4.1 Vea Impex (I) Pvt. Ltd. Company Information
  21. 7.4.2 Vea Impex (I) Pvt. Ltd. Business Overview
  22. 7.4.3 Vea Impex (I) Pvt. Ltd. Aprepitant Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Vea Impex (I) Pvt. Ltd. Aprepitant Product Portfolio
  24. 7.4.5 Vea Impex (I) Pvt. Ltd. Recent Developments
  25. 7.5 Heron Therapeutics
  26. 7.5.1 Heron Therapeutics Company Information
  27. 7.5.2 Heron Therapeutics Business Overview
  28. 7.5.3 Heron Therapeutics Aprepitant Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Heron Therapeutics Aprepitant Product Portfolio
  30. 7.5.5 Heron Therapeutics Recent Developments
  31. 7.6 Glenmark Pharmaceuticals
  32. 7.6.1 Glenmark Pharmaceuticals Company Information
  33. 7.6.2 Glenmark Pharmaceuticals Business Overview
  34. 7.6.3 Glenmark Pharmaceuticals Aprepitant Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Glenmark Pharmaceuticals Aprepitant Product Portfolio
  36. 7.6.5 Glenmark Pharmaceuticals Recent Developments
  37. 7.7 Aetos Pharma
  38. 7.7.1 Aetos Pharma Company Information
  39. 7.7.2 Aetos Pharma Business Overview
  40. 7.7.3 Aetos Pharma Aprepitant Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Aetos Pharma Aprepitant Product Portfolio
  42. 7.7.5 Aetos Pharma Recent Developments
  43. 7.8 Actiza Pharmaceutical
  44. 7.8.1 Actiza Pharmaceutical Company Information
  45. 7.8.2 Actiza Pharmaceutical Business Overview
  46. 7.8.3 Actiza Pharmaceutical Aprepitant Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Actiza Pharmaceutical Aprepitant Product Portfolio
  48. 7.8.5 Actiza Pharmaceutical Recent Developments
  49. 7.9 Aark Pharmaceuticals
  50. 7.9.1 Aark Pharmaceuticals Company Information
  51. 7.9.2 Aark Pharmaceuticals Business Overview
  52. 7.9.3 Aark Pharmaceuticals Aprepitant Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Aark Pharmaceuticals Aprepitant Product Portfolio
  54. 7.9.5 Aark Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Aprepitant Market Size by Type
  2. 8.1.1 North America Aprepitant Revenue by Type (2021-2032)
  3. 8.1.2 North America Aprepitant Sales by Type (2021-2032)
  4. 8.1.3 North America Aprepitant Price by Type (2021-2032)
  5. 8.2 North America Aprepitant Market Size by Application
  6. 8.2.1 North America Aprepitant Revenue by Application (2021-2032)
  7. 8.2.2 North America Aprepitant Sales by Application (2021-2032)
  8. 8.2.3 North America Aprepitant Price by Application (2021-2032)
  9. 8.3 North America Aprepitant Market Size by Country
  10. 8.3.1 North America Aprepitant Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Aprepitant Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Aprepitant Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Aprepitant Market Size by Type
  2. 9.1.1 Europe Aprepitant Revenue by Type (2021-2032)
  3. 9.1.2 Europe Aprepitant Sales by Type (2021-2032)
  4. 9.1.3 Europe Aprepitant Price by Type (2021-2032)
  5. 9.2 Europe Aprepitant Market Size by Application
  6. 9.2.1 Europe Aprepitant Revenue by Application (2021-2032)
  7. 9.2.2 Europe Aprepitant Sales by Application (2021-2032)
  8. 9.2.3 Europe Aprepitant Price by Application (2021-2032)
  9. 9.3 Europe Aprepitant Market Size by Country
  10. 9.3.1 Europe Aprepitant Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Aprepitant Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Aprepitant Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Aprepitant Market Size by Type
  2. 10.1.1 China Aprepitant Revenue by Type (2021-2032)
  3. 10.1.2 China Aprepitant Sales by Type (2021-2032)
  4. 10.1.3 China Aprepitant Price by Type (2021-2032)
  5. 10.2 China Aprepitant Market Size by Application
  6. 10.2.1 China Aprepitant Revenue by Application (2021-2032)
  7. 10.2.2 China Aprepitant Sales by Application (2021-2032)
  8. 10.2.3 China Aprepitant Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Aprepitant Market Size by Type
  2. 11.1.1 Asia Aprepitant Revenue by Type (2021-2032)
  3. 11.1.2 Asia Aprepitant Sales by Type (2021-2032)
  4. 11.1.3 Asia Aprepitant Price by Type (2021-2032)
  5. 11.2 Asia Aprepitant Market Size by Application
  6. 11.2.1 Asia Aprepitant Revenue by Application (2021-2032)
  7. 11.2.2 Asia Aprepitant Sales by Application (2021-2032)
  8. 11.2.3 Asia Aprepitant Price by Application (2021-2032)
  9. 11.3 Asia Aprepitant Market Size by Country
  10. 11.3.1 Asia Aprepitant Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Aprepitant Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Aprepitant Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Aprepitant Market Size by Type
  2. 12.1.1 SAMEA Aprepitant Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Aprepitant Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Aprepitant Price by Type (2021-2032)
  5. 12.2 SAMEA Aprepitant Market Size by Application
  6. 12.2.1 SAMEA Aprepitant Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Aprepitant Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Aprepitant Price by Application (2021-2032)
  9. 12.3 SAMEA Aprepitant Market Size by Country
  10. 12.3.1 SAMEA Aprepitant Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Aprepitant Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Aprepitant Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Aprepitant Value Chain Analysis
  2. 13.1.1 Aprepitant Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Aprepitant Production Mode & Process
  6. 13.2 Aprepitant Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Aprepitant Distributors
  9. 13.2.3 Aprepitant Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst